» Articles » PMID: 27833089

Effects of Continuous Renal Replacement Therapy on Serum Cytokines, Neutrophil Gelatinase-associated Lipocalin, and Prognosis in Patients with Severe Acute Kidney Injury After Cardiac Surgery

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Nov 12
PMID 27833089
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of our study was to evaluate the effect of continuous renal replacement therapy (CRRT) on serum cytokines, neutrophil gelatinase-associated lipocalin (NGAL), and prognosis in patients with severe acute kidney injury (AKI) following cardiac surgery. A total number of 153 patients with severe AKI following cardiac surgery were treated with CRRT. They were divided into the survival and non-survival groups. Clinical data from these two groups before and after CRRT were recorded and analyzed. It was found that the number of impaired organs, MODS and APACHE II scores were significantly higher in the non-survival group than those in the survival group before CRRT. After CRRT, MODS and APACHE II scores decreased significantly. The post-CRRT levels of serum TNF-α and IL-6 were significantly decreased. After CRRT, serum NGAL decreased in the two groups, but the levels were higher in the non-survival group than those in the survival group. MODS and APACHE II scores could be used to evaluate the severity of AKI in patients after cardiac surgery. CRRT is an effective treatment for these patients and high levels of TNF-α, IL-6, and NGAL are associated with a poor prognosis in these patients.

Citing Articles

COUP-TFII in Kidneys, from Embryos to Sick Adults.

Ishii S, Koibuchi N Diagnostics (Basel). 2022; 12(5).

PMID: 35626336 PMC: 9139597. DOI: 10.3390/diagnostics12051181.


The Prognostic Value of Calcium in Post-Cardiovascular Surgery Patients in the Intensive Care Unit.

Bi S, Liu R, Li J, Chen S, Gu J Front Cardiovasc Med. 2021; 8:733528.

PMID: 34676253 PMC: 8523822. DOI: 10.3389/fcvm.2021.733528.


HELLP! The Novel Use of Continuous Renal Replacement Therapy and Nitric Oxide in the Treatment of Acute Respiratory Failure in HELLP Syndrome.

Azimi-Ghomi O, Miller G, Guida C, Marimon A, Boneva D, Mckenney M Case Rep Crit Care. 2021; 2021:8895319.

PMID: 34422416 PMC: 8373477. DOI: 10.1155/2021/8895319.


Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?.

Constantinescu C, Pasca S, Tat T, Teodorescu P, Vlad C, Iluta S J Immunother Cancer. 2020; 8(1).

PMID: 32474415 PMC: 7264828. DOI: 10.1136/jitc-2020-000742.

References
1.
Knaus W, Zimmerman J, Wagner D, Draper E, LAWRENCE D . APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med. 1981; 9(8):591-7. DOI: 10.1097/00003246-198108000-00008. View

2.
Englberger L, Suri R, Li Z, Casey E, Daly R, Dearani J . Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care. 2011; 15(1):R16. PMC: 3222049. DOI: 10.1186/cc9960. View

3.
Pickering J, James M, Palmer S . Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies. Am J Kidney Dis. 2014; 65(2):283-93. DOI: 10.1053/j.ajkd.2014.09.008. View

4.
Soni S, Ronco C, Katz N, Cruz D . Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif. 2009; 28(3):165-74. DOI: 10.1159/000227785. View

5.
Lacquaniti A, Chirico V, Donato V, Briuglia S, Cernaro V, Gallizzi R . NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. Ren Fail. 2012; 34(4):495-8. DOI: 10.3109/0886022X.2011.649677. View